Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gelsectan in Post-infectious and Non-infectious IBS
NCT05045768Phase 4Completed
- Sponsor
- Evangelismos Hospital
- Start
- Sep 2021
- Primary completion
- Feb 2024
- Modality
- Peptides, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of Gelsectan in irritable bowel syndrome (IBS), sponsored by Evangelismos Hospital. Started Sep 2021; status: completed.
02
Drugs
Gelsectan
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT05045768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05045768.